Magee L A, Abdullah S
Department of Specialized Women's Health, BC Women's Hospital and Health Centre, 4500 Oak Street, Room IU59, Vancouver, BCV6H 3N1, Canada.
Expert Opin Drug Saf. 2004 Jan;3(1):25-38. doi: 10.1517/14740338.3.1.25.
This review addresses the maternal and perinatal benefits and risks of antihypertensive therapy in pregnancy. It covers the diagnosis of hypertension in pregnancy (with a brief discussion of ambulatory blood pressure measurement) followed by both the general principles of management of pregnancy hypertension and the specifics of individual antihypertensive drugs and drug classes. Discussion is focused on quantitative overviews of randomised, controlled trials, although observational literature is also discussed, particularly in reference to the potential teratogenicity of agents and the safety of their administration to nursing mothers. The treatment of severe hypertension is addressed separately from the treatment of mild-to-moderate hypertension, for which the maternal and fetal risks are substantially different.
本综述探讨了孕期抗高血压治疗对孕产妇及围产期的益处和风险。内容涵盖孕期高血压的诊断(简要讨论动态血压测量),随后是孕期高血压管理的一般原则以及各类抗高血压药物的具体情况。讨论重点是随机对照试验的定量综述,不过也会讨论观察性文献,特别是关于药物潜在致畸性及其对哺乳期母亲用药安全性的文献。重度高血压的治疗与轻度至中度高血压的治疗分开讨论,因为二者对孕产妇和胎儿的风险有很大差异。